Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Sunshine Biopharma stock

Learn how to easily invest in Sunshine Biopharma stock.

Sunshine Biopharma is conducting a public offering of units comprised of one share of common stock and one warrant exercisable for one share of common stock. The offering, however, is contingent upon the approval of the company's application for listing on the Nasdaq.

The company's stock currently trades on the Over-the-Counter Markets pink sheets under the ticker symbol "SBFM." If its application is approved, it will trade on the Nasdaq under the same ticker symbol.

How to buy shares in Sunshine Biopharma

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SBFM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Sunshine Biopharma stock price (NASDAQ: SBFM)

Use our graph to track the performance of SBFM stocks over time.

Sunshine Biopharma shares at a glance

Information last updated 2022-09-23.
Latest market close$0.83
52-week range$0.70 - $29.80
50-day moving average $1.11
200-day moving average $1.93
Wall St. target priceN/A
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.21

Buy Sunshine Biopharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 8 of 8
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Sunshine Biopharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Sunshine Biopharma price performance over time

Historical closes compared with the close of $0.8286 from 2022-09-26

1 week (2022-09-20) -3.65%
1 month (2022-08-26) -26.02%
3 months (2022-06-28) -29.18%
6 months (2022-03-28) -66.86%
1 year (2021-09-28) 630.04%
2 years (2020-09-25) 4,503.33%
3 years (2019-09-27) 45,933.33%
5 years (2017-09-27) 5,211.54%

Sunshine Biopharma financials

Revenue TTM $408,446
Gross profit TTM $110,596
Return on assets TTM -7.69%
Return on equity TTM -25.1%
Profit margin 0%
Book value $2.22
Market capitalisation $15.2 million

TTM: trailing 12 months

Sunshine Biopharma share dividends

We're not expecting Sunshine Biopharma to pay a dividend over the next 12 months.

You may also wish to consider:

Have Sunshine Biopharma's shares ever split?

Sunshine Biopharma's shares were split on a 1:200 basis on 9 February 2022. So if you had owned 200 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Sunshine Biopharma shares – just the quantity. However, indirectly, the new 19900% higher share price could have impacted the market appetite for Sunshine Biopharma shares which in turn could have impacted Sunshine Biopharma's share price.

Sunshine Biopharma share price volatility

Over the last 12 months, Sunshine Biopharma's shares have ranged in value from as little as $0.701 up to $29.8. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sunshine Biopharma's is -1.6848. This would suggest that Sunshine Biopharma's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Sunshine Biopharma has bucked the trend.

To put Sunshine Biopharma's beta into context you can compare it against those of similar companies.

Sunshine Biopharma overview

Sunshine Biopharma, Inc. , a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.

Frequently asked questions

What percentage of Sunshine Biopharma is owned by insiders or institutions?
Currently 3.094% of Sunshine Biopharma shares are held by insiders and 3.984% by institutions.
How many people work for Sunshine Biopharma?
Latest data suggests 3 work at Sunshine Biopharma.
When does the fiscal year end for Sunshine Biopharma?
Sunshine Biopharma's fiscal year ends in December.
Where is Sunshine Biopharma based?
Sunshine Biopharma's address is: 6500 Trans-Canada Highway, Pointe-Claire, QC, Canada, H9R 0A5
What is Sunshine Biopharma's ISIN number?
Sunshine Biopharma's international securities identification number is: US8677814035

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site